Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON AUROBINDO PHARMA BIOCON /
AUROBINDO PHARMA
 
P/E (TTM) x 19.7 23.0 85.7% View Chart
P/BV x 1.8 2.4 75.8% View Chart
Dividend Yield % 0.6 0.3 206.2%  

Financials

 BIOCON    AUROBINDO PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-23
AUROBINDO PHARMA
Mar-23
BIOCON /
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs388715 54.3%   
Low Rs192397 48.2%   
Sales per share (Unadj.) Rs93.1424.2 21.9%  
Earnings per share (Unadj.) Rs5.432.9 16.3%  
Cash flow per share (Unadj.) Rs14.654.1 27.0%  
Dividends per share (Unadj.) Rs1.503.00 50.0%  
Avg Dividend yield %0.50.5 96.0%  
Book value per share (Unadj.) Rs146.5458.1 32.0%  
Shares outstanding (eoy) m1,200.60585.94 204.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.11.3 237.5%   
Avg P/E ratio x54.116.9 320.1%  
P/CF ratio (eoy) x19.810.3 192.9%  
Price / Book Value ratio x2.01.2 162.9%  
Dividend payout %28.09.1 307.1%   
Avg Mkt Cap Rs m347,814325,753 106.8%   
No. of employees `000NANA-   
Total wages/salary Rs m21,81035,223 61.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,742248,554 45.0%  
Other income Rs m7,6812,906 264.3%   
Total revenues Rs m119,423251,460 47.5%   
Gross profit Rs m16,61137,070 44.8%  
Depreciation Rs m11,13112,446 89.4%   
Interest Rs m4,1901,405 298.3%   
Profit before tax Rs m8,97126,125 34.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5416,849 37.1%   
Profit after tax Rs m6,43019,277 33.4%  
Gross profit margin %14.914.9 99.7%  
Effective tax rate %28.326.2 108.0%   
Net profit margin %5.87.8 74.2%  
BALANCE SHEET DATA
Current assets Rs m123,340214,599 57.5%   
Current liabilities Rs m85,107114,938 74.0%   
Net working cap to sales %34.240.1 85.3%  
Current ratio x1.41.9 77.6%  
Inventory Days Days12921 625.7%  
Debtors Days Days11766 178.0%  
Net fixed assets Rs m394,078176,668 223.1%   
Share capital Rs m6,003586 1,024.6%   
"Free" reserves Rs m169,926267,813 63.4%   
Net worth Rs m175,929268,399 65.5%   
Long term debt Rs m152,9056,190 2,470.4%   
Total assets Rs m517,418392,125 132.0%  
Interest coverage x3.119.6 16.0%   
Debt to equity ratio x0.90 3,768.8%  
Sales to assets ratio x0.20.6 34.1%   
Return on assets %2.15.3 38.9%  
Return on equity %3.77.2 50.9%  
Return on capital %4.010.0 39.9%  
Exports to sales %3.133.7 9.2%   
Imports to sales %6.015.3 38.9%   
Exports (fob) Rs m3,46783,703 4.1%   
Imports (cif) Rs m6,65438,060 17.5%   
Fx inflow Rs m3,46785,483 4.1%   
Fx outflow Rs m6,65441,447 16.1%   
Net fx Rs m-3,18744,036 -7.2%   
CASH FLOW
From Operations Rs m18,52523,868 77.6%  
From Investments Rs m-142,818-39,778 359.0%  
From Financial Activity Rs m130,48718,144 719.2%  
Net Cashflow Rs m6,4112,298 279.0%  

Share Holding

Indian Promoters % 40.4 48.8 82.8%  
Foreign collaborators % 20.3 3.1 660.6%  
Indian inst/Mut Fund % 21.1 41.3 51.0%  
FIIs % 6.6 20.7 31.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 48.2 81.7%  
Shareholders   434,339 241,944 179.5%  
Pledged promoter(s) holding % 0.0 20.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Biocon vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Aurobindo Pharma Share Price Performance

Period Biocon Aurobindo Pharma S&P BSE HEALTHCARE
1-Day 3.04% 1.89% 1.18%
1-Month -2.42% 6.04% -0.75%
1-Year 30.66% 113.22% 61.82%
3-Year CAGR -13.51% 7.80% 18.16%
5-Year CAGR -2.70% 7.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

Aurobindo Pharma paid Rs 3.0, and its dividend payout ratio stood at 9.1%.

You may visit here to review the dividend history of Biocon, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.